Advertisement

Topics

Neurosciences Victoria Limited Company Profile

05:27 EDT 23rd September 2017 | BioPortfolio

Our MissionNSV is dedicated to the continued development of the world-class neuroscience biocluster in Melbourne, Australia through a program of strategic investment in the gap between academic discovery research and commercial development.



By providing focus and direction for neuroscience research and through the creation and development of strong industry partnerships, NSV provides a unique and effective interface between neuroscientists, the biotechnology and pharmaceutical industries, investors and public funding bodies.



Aims of NSV



To support research and discovery for the prevention, diagnosis, therapy and cure of neurological and psychiatric conditions

To attract and sustain funding and investment into neuroscience R & D

To provide commercialisation services and brokerage of intellectual property and research capabilities

To translate neuroscience research discoveries into commercial applications and improved clinical practice

To provide direction for neuroscience research so that the social and economic potential offered by neuroscience research is realised

To promote and facilitate large-scale collaborative research programs

Location

Level 2, 161 Barry Street
Carlton South
Melbourne
VIC
3053
Australia

Contact

Phone: +61 (0)3 8344 1802
Fax: +61 (0)3 9348 1764
Email: william.hart@neurosciencesvic.com.au


News Articles [154 Associated News Articles listed on BioPortfolio]

ProMIS Neurosciences: ProMIS Neurosciences Independent Director Anthony J. Giovinazzo Recognized with Inaugural Bloom Burton Award for Innovation in Canadian Healthcare

ProMISTM Neurosciences, Inc. NEWS RELEASE TSX: PMN TORONTO, ONTARIO and CAMBRIDGE, MA - September 21, 2017 - ProMIS Neurosciences, Inc., a company focused on the discovery and development of preci...

ProMIS Neurosciences: ProMIS Neurosciences Completes First Closing of Private Placement

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ONTARIO - August 9, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:A...

ProMIS Neurosciences: ProMIS Neurosciences Announces CDN$3 Million Best-Efforts Private Placement

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ON - July 20, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:ARFX.F;...

ProMIS Neurosciences: ProMIS Neurosciences Increases Size of Private Placement to $6 Million

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ONTARIO - August 2, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:A...

ProMIS Neurosciences: ProMIS Neurosciences Appoints William C. Mobley to Scientific Advisory Board

TORONTO and CAMBRIDGE, Mass., June 06, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX:PMN), a biotechnology company focused on the discovery and development of precision treatments for n...

Minerva Neurosciences, Inc.: Minerva Neurosciences, Inc. to Offer Common Shares

WALTHAM, Mass., 2017-06-27 22:10 CEST (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell 5,00...

ProMIS Neurosciences: ProMIS Neurosciences Announces Q1 2017 Annual Results

TORONTO, Ontario - May 9, 2017 - ProMIS Neurosciences, Inc. (TSX:PMN) ("ProMIS" or the "Company"), a company focused on the discovery and development of precision treatments for neurodegenerative ...

ProMIS Neurosciences: ProMIS Neurosciences Announces Second Quarter 2017 Results

TORONTO and CAMBRIDGE, Mass., Aug. 11, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. ("ProMIS" or the "Company"), a company focused on the discovery and development of precision treatments f...

PubMed Articles [173 Associated PubMed Articles listed on BioPortfolio]

Infectious diseases notification practices, Victoria 2013.

Infectious disease notification practices in Victoria were reviewed to identify areas for potential improvement.

Maternal region of birth and stillbirth in Victoria, Australia 2000-2011: A retrospective cohort study of Victorian perinatal data.

There is growing evidence from high-income countries that maternal country of birth is a risk factor for stillbirth. We aimed to examine the association between maternal region of birth and stillbirth...

Q&A: Victoria Blair.

Indoor residual spraying with micro-encapsulated pirimiphos-methyl (Actellic® 300CS) against malaria vectors in the Lake Victoria basin, Tanzania.

The indoor residual spraying programme for malaria vectors control was implemented in four districts of the Lake Victoria basin of Tanzania namely Ukerewe, Sengerema, Rorya andSerengeti. Entomological...

Population attributable fraction of incident HIV infections associated with alcohol consumption in fishing communities around Lake Victoria, Uganda.

Although the association between alcohol consumption and HIV risk is well documented, few studies have examined the magnitude of new HIV infections that could be prevented by controlling alcohol use. ...

Clinical Trials [26 Associated Clinical Trials listed on BioPortfolio]

The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda

The overall objective of the project is to contribute to an increased knowledge about the effect of praziquantel on schistosomiasis related morbidity and re-infection level among communiti...

TIV Infant/Toddler Response Evaluation - Follow-up for Influenza B Boost

Each winter, viruses belonging to two kinds of influenza A ("A/H1N1" & "A/H3N2") and two kinds of influenza B ("B/Yamagata" & "B/Victoria") can cause illness. The yearly influenza vaccine ...

Enhancing Social Interaction With an AlterEgo Artificial Agent

The objective of AlterEgo is the creation of an interactive cognitive architecture, implementable in various artificial agents, allowing a continuous interaction with patients suffering fr...

A Study to Evaluate the Immunogenicity of MEDI3250 in Adults 18 to 49 Years of Age

The objective of this study is to prove that MEDI3250 is at least as effective as two different forms the vaccine, FluMist, by comparing the specific events after dosage.

V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis

This is an 18 week (2 weeks run-in, 16 weeks double blind) trial, to determine if an antiviral drug, valacyclovir (Valtrex) is helpful in treating the symptoms of psychosis, a form of a me...

Companies [160 Associated Companies listed on BioPortfolio]

Invest Victoria

Invest Victoria is the investment promotion agency of the State Government of Victoria, Australia. Invest Victoria provides a single entry point to a range of business and investment services for comp...

Merz Neurosciences

Merz Neurosciences is a division of Merz North America, a specialty healthcare company that develops and commercializes treatment solutions in aesthetics, dermatology and neurosci...

National Neuroscience Facility

The National Neuroscience Facility (NNF) was created as a result of Major National Research Facility (MNRF) and Science, Technology and Innovation (STI) grants of $18 million and $4.5 million from the...

Circadian Technologies Limited

Circadian Technologies Limited is an emerging leader in the field of angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs),...

LV=

LV= is a registered trade mark of Liverpool Victoria Friendly Society Limited (LVFS) and a trading style of the Liverpool Victoria group of companies. LV= offer a range of insurance products including...

More Information about "Neurosciences Victoria Limited" on BioPortfolio

We have published hundreds of Neurosciences Victoria Limited news stories on BioPortfolio along with dozens of Neurosciences Victoria Limited Clinical Trials and PubMed Articles about Neurosciences Victoria Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neurosciences Victoria Limited Companies in our database. You can also find out about relevant Neurosciences Victoria Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...


Corporate Database Quicklinks



Searches Linking to this Company Record